参考文献/References:
［1］ SAEEDI P，SALPEA P，KARURANGA S，et al．Mortality attributable to diabetes in 20-79 years old adults，2019 estimates：results from the international diabetes federation diabetes atlas，9 edition［J］．Diabetes Res Clin Pract，2020，21(10)：80-86．
［2］ CHOI J B，YOO J M，LEE Y J，et al．Effect of the sodium-glucose cotransporter 2 inhibitor，dapagliflozin，on genitourinary infection in an animal model of type 2 diabetes［J］．Int Neurourol J，2020，24(1)：21-28．
［3］ WONGKRASANT P，PONGKORPSAKOL P，CHITWATTANANONT S，et al．Fructo-oligosaccharides alleviate inflammation-associated apoptosis of GLP-1 secreting L cells via inhibition of inos and cleaved caspase-3 expression［J］．J Pharmacol Sci，2020，143(2)：65-73．
［4］ YAP Y A,MARIN~O E．Dietary SCFAs immunotherapy：reshaping the gut microbiota in diabetes［J］．Adv Exp Med Biol，2020，10(7)：10-15．
［5］ LUU M,VISEKRUNA A．Short-chain fatty acids：bacterial messengers modulating the immunometabolism of T cells［J］．Eur J Immunol，2019，49(9)：842-848．
［6］ YORK A．Your microbiome is what you eat［J］．Nat Rev Microbiol，2019，17(12)：720-721．
［7］ METZLER-ZEBELI B U，CANIBE N，MONTAGNE L，et al．Resistant starch reduces large intestinal pH and promotes fecal lactobacilli and bifidobacteria in pigs［J］．Animal，2019，13(1)：64-73．
［8］ VALLIANOU N G，STRATIGOU T．Microbiome and diabetes：where are we now［J］．Diabetes Res Clin Pract，2018，14(6)：111-118．
［9］ 张洪阳，韩新生，徐建可，等．血清胱抑素C、尿微量白蛋白与老年急性脑梗死合并2型糖尿病患者病情严重程度及血糖变化的相关性［J］．新乡医学院学报，2019，36(5)：448-451．
［10］ ZHU L，SHA L，LI K，et al．Dietary flaxseed oil rich in omega-3 suppresses severity of type 2 diabetes mellitus via anti-inflammation and modulating gut microbiota in rats［J］．Lipids Health Dis，2020，19(1)：17-20．
［11］ HE D，HUANG J H，ZHANG Z Y，et al．A network pharmacology-based strategy for predicting active ingredients and potential targets of Liu Wei Di Huang pill in treating type 2 diabetes mellitus［J］．Drug Des Devel Ther，2019，13(12)：3989-4005．
［12］ WANG Y，ZHANG K，QI X，et al．Effects of propofol on LC3II and mTOR/p-mTOR expression during ischemia-reperfusion myocardium injury in rats with type 2 diabetes mellitus［J］．Exp Ther Med，2020，19(4)：2441-2448．
［13］ KIERNAN K,MACIVER N J．A novel mechanism for Th17 inflammation in human type 2 diabetes mellitus［J］．Trends Endocrinol Metab，2020，31(1)：1-2．
［14］ MAHABADI-ASHTIYANI E，SHEIKH V，BORZOUEI S，et al．The increased T helper cells proliferation and inflammatory responses in patients with type 2 diabetes mellitus is suppressed by sitagliptin and vitamin D3 in vitro［J］．Inflamm Res，2019，68(10)：857-866．
［15］ WANG X，YANG L，CHENG Y，et al．Down regulation of T-Cell transcription factors in adult latent autoimmune diabetes with high-titer glutamic acid decaroxylase antibody［J］．Diabetes Ther，2019，10(3)：917-927．
［16］ GALSTYAN K O，NEDOSUGOVA L V，MARTIROSIAN N S，et al．Modification of tumor necrosis factor-α and C-C Motif chemokine ligand 18 secretion by monocytes derived from patients with diabetic foot syndrome［J］．Biology，2019，9(1)：1-3．
［17］ WONG U,CROSS R K．Expert opinion on interleukin-12/23 and interleukin-23 antagonists as potential therapeutic options for the treatment of inflammatory bowel disease［J］．Expert Opin Investig Drugs，2019，28(5)：473-479．
［18］ LSSIGER-HERFURTH A，PONTAROLLO G，GRILL A．The gut microbiota in cardiovascular disease and arterial thrombosis［J］．Microorganisms，2019，7(12)：691．
［19］ CHASSAING B,GEWIRTZ A T．Mice harboring pathobiont-free microbiota do not develop intestinal inflammation that normally results from an innate immune deficiency［J］．PLoS One，2018，13(4)：3-10．
［20］ DELGADO G E，KRAMER B K，SCHARNAGL H，et al．Bile Acids in patients with uncontrolled type 2 diabetes mellitus-the effect of two days of oatmeal treatment［J］．Exp Clin Endocrinol Diabetes，2020，73(30)：1055-1069．
［21］ JIA W，XIE G,JIA W．Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis［J］．Nat Rev Gastroenterol Hepatol，2018，15(2)：111-128．
［22］ GADALETA R M，GARCIA-IRIGOYEN O，CARIELLO M，et al．Fibroblast growth factor 19 modulates intestinal microbiota and inflammation in presence of farnesoid X receptor［J］．EBioMedicine，2020，54(10)：19-27．
［23］ DINAN T G,CRYAN J F．The microbiome-gut-brain axis in health and disease［J］．Gastroenterol Clin North Am，2017，46(1)：77-89．
［24］ HOLLY J M P，BIERNACKA K,PERKS C M．The neglected insulin：IGF-II，a metabolic regulator with implications for diabetes，obesity，and cancer［J］．Cells，2019，8(10)：7-12．
［25］ KAISANLAHTI A,GLUMOFF T．Browning of white fat:agents and implications for beige adipose tissue to type 2 diabetes［J］．J Physiol Biochem，2019，75(1)：1-10．
［26］ LOH K，SHI Y C，BENSELLAM M，et al．Y1 receptor deficiency in β-cells leads to increased adiposity and impaired glucose metabolism［J］．Sci Rep，2018，8(1)：28-35．
［27］ YANG X，CHENG X，TANG Y，et al．Bacterial endotoxin activates the coagulation cascade through gasdermin D-Dependent phosphatidylserine exposure［J］．Immunity，2019，51(6)：983-996．
［28］ CANI P D，POSSEMIERS S， WIELE T V D，et al．Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability［J］．Gut，2009，58(8)：1091-1103．
［29］ LU Y C，YEH W C,OHASHI P S.LPS/TLR4 signal transduction pathway［J］．Cytokine，2008，42(2)：145-151．
［30］ PAN Z K．Toll-like receptors and TLR-mediated signaling：more questions than answers［J］．Am J Physiol Lung Cell Mol Physiol，2004，286(5)：918-928．
［31］ TAKAGURI A．Elucidation of a new mechanism of onset of insulin resistance：effects of statins and tumor necrosis factor-α on insulin signal transduction［J］．Yakugaku Zasshi，2018，138(11)：1329-1334．
［32］ DELZENNE N M，CANI P D.Nutritional modulation of gut microbiota in the context of obesity and insulin resistance：potential interest of prebiotics［J］．Int Dairy J，2010，20(4)：277-280．
［33］ CHEPURNY O G，MATSOUKAS M T，LIAPAKIS G，et al．Nonconventional glucagon and GLP-1 receptor agonist and antagonist interplay at the GLP-1 receptor revealed in high-throughput fret assays for cAMP［J］．J Biol Chem，2019，294(10)：3514-3531．
［34］ LAFFERTY R A，FLATT P R,IRWIN N．Emerging therapeutic potential for peptide YY for obesity-diabetes［J］．Peptides，2018，100(24)：269-274．
［35］ CHAIT A,DEN HARTIGH L J．Adipose tissue distribution,inflammation and its metabolic consequences,including diabetes and cardiovascular disease［J］．Front Cardiovasc Med，2020，7(15)：21-22．
［36］ KJAERGAARD M，SALINAS C，REHFELD J F，et al．PYY(3-36) and exendin-4 reduce food intake and activate neuronal circuits in a synergistic manner in mice［J］.Neuropeptides，2019，73(2)：89-95．
［37］ YIN W L，BAIN S C,MIN T．The effect of glucagon-like peptide-1 receptor agonists on renal outcomes in type 2 diabetes［J］．Diabetes Ther，2020，11(4)：835-844．
［38］ ADAMS J M，PEI H，SANDOVAL D A，et al．Liraglutide modulates appetite and body weight through glucagon-like peptide 1 receptor-expressing gutamatergic neurons［J］．Diabetes，2018，67(8)：1538-1548．
［39］ LUO Y，YANG P，LI Z，et al．Liraglutide improves non-alcoholic fatty liver disease in diabetic mice by modulating inflammatory signaling pathways［J］．Drug Des Develo Ther，2019，13(5)：4065-4074．
［40］ MCDONALD B D，JABRI B,BENDELAC A.Diverse developmental pathways of intestinal intraepithelial lymphocytes［J］．Nat Rev Immunol，2018，18(8)：514-525．
［41］ HE S，KAHLES F，RATTIK S，et al．Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease［J］．Nature，2019，566(7742)：115-119．
［42］ NIHEI N，OKAMOTO H，FURUNE T，et al．Dietary α-cyclodextrin modifies gut microbiota and reduces fat accumulation in high-fat-diet-fed obese mice［J］．Biofactors,2018，342(45)：231-236．
［43］ PETROVSKY N,SILVA D．The power of an integrated informatic and molecular approach to type 1 diabetes research［J］．Ann N Y Acad Sci，2004，1037(237)：216-224．
［44］ TAN J，MCKENZIE C，POTAMITIS M，et al．The role of short-chain fatty acids in health and disease［J］．Adv Immunol，2014，121(235)：91-119．
［45］ CANFORA E E，BEEK C M，JOCKEN J W E，et al．Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men：a randomized crossover trial［J］．Sci Rep，2017，7(1)：23-28．
［46］ YARIBEYGI H，SATHYAPALAN T，ATKIN S L．Molecular mechanisms linking oxidative stress and diabetes ellitus［J］．Oxid Med Cell Longev，2020，27(2)：736-750．
［47］ ZHANG H X，YANG Y L，WANG Y Q，et al．Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway［J］．Drug Des Devel Ther,2018,12(4):89-98.
［48］ MA Y F，YOU X Y，MAI G Q，et al．A human gut phage catalog correlates the gut phageome with type 2 diabetes［J］．Microbiome，2018，6(1)：24-26．
［49］ ZHAO L，WANG B H，WANG L M，et al．Design,screening and biological evaluation of novel fatty acid chain-modified oxyntomodulin-based derivatives with prolonged glucose-lowering ability and potent anti-obesity effects［J］．Org Biomol Chem，2019，17(33):7760-7771.
［50］ ZHONG X，CHEN Z，CHEN Q，et al．Novel site-specific fatty chain-modified GLP-1 receptor agonist with potent antidiabetic effects［J］．Molecules，2019，24(4):776-779.
相似文献/References:
[1]翁孝刚.2型糖尿病与胰岛B一细胞功能[J].新乡医学院学报,2002,19(03):231.
[2]汪裕荣.血脂康联合小剂量阿司匹林治疗2型糖尿病并高脂血症的长期疗效观察[J].新乡医学院学报,2002,19(05):391.
[3]型糖尿病合并高血压的胰岛素敏感性探讨.2型糖尿病合并高血压的胰岛素敏感性探讨[J].新乡医学院学报,2003,20(02):124.
[4]何伟玺.冠心病与2型糖尿病患者心率变异性对比分析[J].新乡医学院学报,2003,20(04):282.
[5]李万森,毛向莹,邱培勇.2型糖尿病合并脑梗死50例临床分析[J].新乡医学院学报,2003,20(05):353.
[6]殷国田,崔瑞花.益津降糖胶囊治疗2型糖尿病42例[J].新乡医学院学报,2003,20(05):372.
[7]新乡市第二人民医院内分泌科 河南新乡.依那普利对2型糖尿病合并高血压患者血压及胰岛素敏感性指数的影响[J].新乡医学院学报,2005,22(03):267.
[8]蒋铁桥,张群,杨刚毅,等.短期胰岛素泵强化治疗对初诊2型糖尿病患者β细胞功能的影响[J].新乡医学院学报,2010,27(04):000.
[9]王润之,黄艳群.LPIN1基因的研究进展[J].新乡医学院学报,2010,27(04):413.
[10]姥勇,屈阳,朱旅云,等.脂联素与2型糖尿病血管病变的关系[J].新乡医学院学报,2011,28(01):089.